Clinical Trial: A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata

U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07762443) titled 'A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata' on Aug. 09.

Brief Summary: This study is a multicenter, open-label, non-randomized, dose-finding Phase I study designed to evaluate the pharmacokinetics (PK), safety, and preliminary efficacy of VC005 tablets in adolescent subjects with severe alopecia areata (AA).

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Alopecia Areata

Intervention: DRUG: VC005 tablets

VC005 repeat administration for 24 weeks

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD

Published by HT Digital Co...